Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Authors
Keywords
-
Journal
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-15
DOI
10.1007/s10741-020-10063-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation
- (2020) Carmine Rocca et al. ANTIOXIDANTS & REDOX SIGNALING
- Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
- (2020) Mohammad Sheibani et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Empagliflozin prevents doxorubicin-induced myocardial dysfunction
- (2020) Jolanda Sabatino et al. Cardiovascular Diabetology
- The cancer patient and cardiology
- (2020) José Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- SEOM clinical guidelines on cardiovascular toxicity (2018)
- (2019) J. A. Virizuela et al. Clinical & Translational Oncology
- Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT
- (2019) Zaitulhusna M. Safee et al. Scientific Reports
- Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity
- (2019) Carlos Galán-Arriola et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity
- (2019) Michele Russo et al. EUROPEAN JOURNAL OF HEART FAILURE
- Long term cardiovascular magnetic resonance phenotyping of anthracycline cardiomyopathy
- (2019) Iwan Harries et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Teneligliptin prevents doxorubicin-induced inflammation and apoptosis in H9c2 cells
- (2019) Wen Peng et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
- (2018) Pierre Frères et al. BMC CANCER
- The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC
- (2018) Stefan Frantz et al. EUROPEAN JOURNAL OF HEART FAILURE
- Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
- (2018) Peter Reichardt et al. Future Oncology
- Splenic leukocytes define the resolution of inflammation in heart failure
- (2018) Ganesh V. Halade et al. Science Signaling
- Splenic leukocytes define the resolution of inflammation in heart failure
- (2018) Ganesh V. Halade et al. Science Signaling
- Meta-analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity
- (2018) Babikir Kheiri et al. AMERICAN JOURNAL OF CARDIOLOGY
- Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters inflammation-resolution program in the myocardium
- (2018) Jeevan Kumar Jadapalli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis
- (2018) Chrysanthos Grigoratos et al. HEART FAILURE REVIEWS
- Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational18F-FDG PET/CT Observation
- (2017) Matteo Bauckneht et al. JOURNAL OF NUCLEAR MEDICINE
- Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
- (2017) Siri Lagethon Heck et al. European Heart Journal-Cardiovascular Imaging
- Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy
- (2016) Giovanni Donato Aquaro et al. AMERICAN JOURNAL OF CARDIOLOGY
- Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac DysfunctionNovelty and Significance
- (2016) Lynn A. Beer et al. CIRCULATION RESEARCH
- Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer SurvivorsCLINICAL PERSPECTIVE
- (2016) Jennifer H. Jordan et al. Circulation-Cardiovascular Imaging
- Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts
- (2016) Pei-Yu Chen et al. ENVIRONMENTAL TOXICOLOGY
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats
- (2016) A Sheta et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss
- (2016) Daniela Cardinale et al. Current Cardiology Reports
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
- (2015) M. Putt et al. CLINICAL CHEMISTRY
- Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group
- (2015) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors
- (2014) S. H. Armenian et al. CLINICAL CANCER RESEARCH
- Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients
- (2014) Alix E. Seif et al. PEDIATRIC BLOOD & CANCER
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) J. C. Plana et al. European Heart Journal-Cardiovascular Imaging
- High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy
- (2014) Kenichi Katsurada et al. SpringerPlus
- The role of antioxidants in the era of cardio-oncology
- (2013) Duncan T. Vincent et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy
- (2013) Paaladinesh Thavendiranathan et al. Circulation-Cardiovascular Imaging
- Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
- (2013) P Vejpongsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers
- (2013) Suchi Grover et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Usefulness of india ink artifact in steady-state free precession pulse sequences for detection and quantification of intramyocardial fat
- (2013) Giovanni Donato Aquaro et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer
- (2013) Kaisa Ylänen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
- (2013) Xavier Bosch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts
- (2013) Kendra K.S. Nordgren et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study
- (2013) Ayşenur Bahadır et al. Turkish Journal of Hematology
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- Dietary Omega-3 Supplementation Exacerbates Left Ventricular Dysfunction in an Ovine Model of Anthracycline-Induced Cardiotoxicity
- (2012) Angelo Carbone et al. JOURNAL OF CARDIAC FAILURE
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
- (2012) Sinziana Seicean et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
- (2011) P. G. Morris et al. CLINICAL CANCER RESEARCH
- Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
- (2011) MARIELE DESSÌ et al. Experimental and Therapeutic Medicine
- Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function
- (2010) Asimina Hiona et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial
- (2009) P Bougnoux et al. BRITISH JOURNAL OF CANCER
- Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer
- (2007) Paul J. Mills et al. BRAIN BEHAVIOR AND IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now